Bogle Investment Management’s ChemoCentryx, Inc. CCXI Stock Holding History

Bogle Investment Management’s Portfolio CCXI Stock Details CCXI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-62,730	Closed	-$826K	–	358
2018 Q2	$826K	Buy	62,730 +41,626	+197%	+$498K	0.06%	221
2018 Q1	$287K	Buy	+21,104	New	+$218K	0.02%	288
2017 Q3	–	Sell	-94,897	Closed	-$888K	–	378
2017 Q2	$888K	Buy	94,897 +23,755	+33%	+$174K	0.06%	229
2017 Q1	$517K	Sell	71,142 -33,857	-32%	-$244K	0.04%	262
2016 Q4	$776K	Buy	104,999 +7,024	+7%	+$50.6K	0.05%	272
2016 Q3	$591K	Buy	97,975 +22,676	+30%	+$107K	0.04%	289
2016 Q2	$338K	Buy	+75,299	New	+$283K	0.02%	347
2013 Q4	–	Sell	-319,868	Closed	-$1.78M	–	370
2013 Q3	$1.78M	Buy	+319,868	New	+$3.46M	0.18%	175

Other funds holding CCXI

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Bogle Investment Management's CCXI Position: Q3 2018 in Review

Bogle Investment Management sold out of ChemoCentryx, Inc. (CCXI) in Q3 2018, closing a stake of 62,730 shares — an estimated $826K sold.

Bogle Investment Management first reported a position in CCXI in Q3 2013 and held it in 8 quarters. The position peaked at $1.78M in Q3 2013. 106 funds tracked by Wall St. Rank hold CCXI as of Q3 2018.

Bogle Investment Management reported no remaining ChemoCentryx, Inc. position as of Q3 2018 after selling out during the quarter.
Bogle Investment Management sold 62,730 ChemoCentryx, Inc. shares in Q3 2018, an estimated $826K.
Bogle Investment Management first reported a position in ChemoCentryx, Inc. in Q3 2013 and held it in 8 quarters.
Bogle Investment Management's ChemoCentryx, Inc. position peaked at $1.78M in Q3 2013.
106 funds tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q3 2018.

Based on Bogle Investment Management's 13F filing for Q3 2018, filed 13 Nov 2018.